Cic edizioni internazionali
Il Giornale di Chirurgia

Whyever bladder tissue engineering clinical applications still remain unusual even though many intriguing technological advances have been reached?

Review, 6 - 12
doi: 10.11138/gchir/2016.37.1.006
Tag this article
Abstract
Enhanced HTML Full text PDF
To prevent problematic outcomes of bowel-based bladder reconstructive surgery, such as prosthetic tumors and systemic metabolic complications, research works, to either regenerate and strengthen failing organ or build organ replacement biosubstitute, have been turned, from 90s of the last century, to both regenerative medicine and tissue engineering.Various types of acellular matrices, naturally-derived materials, synthetic polymers have been used for either “unseeded” (cell free) or autologous “cell seeded” tissue engineering scaffolds. Different categories of cell sources – from autologous differentiated urothelial and smooth muscle cells to natural or laboratory procedure-derived stem cells – have been taken into consideration to reach the construction of suitable “cell seeded” templates. Current clinically validated bladder tissue engineering approaches essentially consist of augmentation cystoplasty in patients suffering from poorly compliant neuropathic bladder. No clinical applications of wholly tissue engineered neobladder have been carried out to radical-reconstructive surgical treatment of bladder malignancies or chronic inflammation-due vesical coarctation.
Reliable reasons why bladder tissue engineering clinical applications so far remain unusual, particularly imply the risk of graft ischemia, hence its both fibrous contraction and even worse perforation.
Therefore, the achievement of graft vascular network (vasculogenesis) could allow, together with the promotion of host surrounding vessel sprouting (angiogenesis), an effective graft blood supply, so avoiding the ischemia-related serious complications.

Vol. XL (No. 2) 2019 March - April

  1. Overview on surgical management of papillary thyroid microcarcinoma
    Ruggiero R., Pirozzi R., Gualtieri G., Terracciano G., Parisi S., Nesta G., Gazaneo L., Lanza Volpe M., Rinaldi S., Docimo L.
  2. Can initial inflammatory markers predict length of stay in uncomplicated diverticulitis?
    Parys S., Eranki A., Khamhing S.
  3. Impact of cardiovascular/diabetic comorbidity on conversion rate during laparoscopic cholecystectomy for acute cholecystitis: a multi-center study on early versus very delayed approach
    Lauro A., Cervellera M., D'Andrea V., Casella G., Di Matteo F.M., Di Matteo F.M., Santoro A., Panarese A., Palazzini G., Cirocchi R., AGastra E., Falvo L., Talarico E., Cicia S., Tonini V.
  4. Surgical intervention for intestinal typhoid perforation
    Nilsson E., Olsson S., Regner S., Polistena A., Ali A., Dedey F., Avenia N., Wu L., Banka Johnson L.
  5. Long-term steroid treatment: a potential risk factor for uterine rupture during pregnancy?
    Grigoriadis C., Tympa A., Delivoria V., Baka S., Theodoraki K.
  6. Postoperative complications, pain and quality of life after thoracoscopic or thoracotomic lobectomy for lung cancer
    Porrello C., Scerrino G., Vaglica A., Palazzolo M., Gagliardo C.M., Giangregorio F., Iadicola D., Tomasello G., Lo Faso F., Kawamukai K., Lacava N., Carini F., Cocorullo G., Gullo R.
  7. Effectiveness of a preventive bundle of measures for reducing surgical site infections in patients undergoing elective orthopedic procedures in a Hellenic Air Force Hospital
    Kritikou G., Avgerinos K.I., Koutserimpas C., Sourri F., Hatzigeorgiou D., Kottaridi C., Bountouris I.
  8. Recurrent giant Brunner’s gland adenoma
    Rodriguez-Quintero J.H., Santes O., Morales-Maza J., Clemente-Gutierrez U., Sanchez-Garcia Ramos E., Cortés-Gonzalez R.
  9. Occasionally report of sacral chordoma; treatment and review of literature
    Sallustio P., Minafra M., Laforgia R., Riccelli U., Lobascio P., Carbotta G., Balducci G., Palasciano N.
  10. Choroidal metastasis from lung adenocarcinoma: a rare case report
    Porrello C., Gullo R., Gagliardo C.M., Vaglica A., Palazzolo M., Giangregorio F., Iadicola D., Profita G., Lo Faso F., Tomasello G., Carini F., Cocorullo G.
  11. Is the social status a new prognostic factor in the Fournier’s gangrene?
    Capasso B., Pezzatini M., Cinquepalmi M., Antonelli M.S., Caraceni G., Rampini A., Cardella S., Castagnola G., Maggi S., Brescia A.
  12. Benign multicystic mesothelioma: a case report of recurrent disease in a young adult with familiarity for renal cell carcinoma
    Falco N., Colli F., Tutino R., Fontana T., Licari L., Rotolo G., Scerrino G., Salamone G., Gulotta G.
  13. Antibiogram in the biopsy of chronic venous ulcers related to sudden changes in the pain profile
    Pereira De Godoy J.M.
  14. An enhanced outpatient modality for the treatment of hemorrhoidal disease: preliminary results
    Perivoliotis K., Spyridakis M., Zintzaras E., Arnaoutoglou E., Pramateftakis M.G., Tepetes K.
  15. Una vita a strati uniti. Il nutrimento e l’esercizio fisico per stare meglio oggi e domani
    Pulcini A.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Whyever bladder tissue engineering clinical applications still remain unusual even though many intriguing technological advances have been reached?
    Alberti C.
    doi: 10.11138/gchir/2016.37.1.006
credits